Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 110.85B, Moderna(MRNA) trades at $277.67. The stock has a price-to-earnings ratio of -31.83.
On 2026-11-09, Moderna(MRNA) stock traded between a low of $253.50 and a high of $280.80. Shares are currently priced at $277.67, which is +9.5% above the low and -1.1% below the high.
Moderna(MRNA) shares are trading with a volume of 8.3M, against a daily average of 12.78M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $280.80 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $280.80 at its peak.
MRNA News
...
Moderna, Inc. (MRNA Quick QuoteMRNA - Free Report) raised its 2026 revenue outlook following stronger-than-expected third-quarter sales, supported by incr...
Biotechnology leaders BioNTech (NASDAQ) and Moderna (NASDAQ) remain heavily reliant on COVID-19 vaccine sales years after the pandemic. For investors, the key q...
Analyst ratings
56%
of 27 ratingsMore MRNA News
Moderna reported third quarter 2026 revenue of US$1.313b and net income of US$162m, raised its full year revenue outlook, trimmed its 2026 R&D budget by US$200m...
On its third-quarter 2026 earnings call, held on Nov. 6, 2026, Moderna (MRNA +5.27%) announced an upgraded full-year revenue framework alongside positive Phase...
Moderna (MRNA) has just flipped the script with its third quarter 2026 results. Revenue reached US$1.313b, and the company reported net income of US$162m after...
Moderna (MRNA Quick QuoteMRNA - Free Report) ) stock has surged as much as 10% in Friday's trading session, reaching a fresh 52-week high of $267 a share a...
Moderna (MRNA +8.71%) earned $162 million in the third quarter, a sharp turn from a $200 million loss a year earlier. Moderna stock rose about 8% in regular tra...
Moderna Inc. (NASDAQ:MRNA) stock traded higher Friday after the vaccine maker reported better-than-expected third-quarter results and raised its full-year reven...
Moderna (MRNA +1.88%) has been one of 2026's biggest stock market winners, rising nearly 720% through Thursday's close. Most of that gain can be attributed to p...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.